Personalized Mitochondrial Medicine (PerMiM): Optimizing diagnostics and treatment for patients with mitochondrial diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055177

Enrollment

Unknown

Registered

2022-01-02

Start date

2022-03-01

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitochondrial disease

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Patients with clinical suspicion of mitochondrial disease and signed informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Identify candidate genes;	—

Countries

China

Contacts

Public ContactFang Fang

Beijing Children's Hospital, Capital Medical University

fangfang@bch.com.cn+86 13370115051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026